132 related articles for article (PubMed ID: 9781597)
1. Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer.
Hempling RE; Piver MS; Eltabbakh GH; Recio FO
Am J Clin Oncol; 1998 Oct; 21(5):447-51. PubMed ID: 9781597
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptors in ovarian cancer.
Harding M; Cowan S; Hole D; Cassidy L; Kitchener H; Davis J; Leake R
Cancer; 1990 Feb; 65(3):486-91. PubMed ID: 2297640
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary.
Geisler JP; Wiemann MC; Miller GA; Geisler HE
Gynecol Oncol; 1996 Mar; 60(3):424-7. PubMed ID: 8774651
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptors and long term survival in invasive ovarian cancer.
Münstedt K; Steen J; Knauf AG; Buch T; von Georgi R; Franke FE
Cancer; 2000 Oct; 89(8):1783-91. PubMed ID: 11042574
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
Yang XY; Xi MR; Yang KX; Yu H
Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of hormonal receptor status of malignant ovarian tumors.
Tkalia IG; Vorobyova LI; Svintsitsky VS; Nespryadko SV; Goncharuk IV; Lukyanova NY; Chekhun VF
Exp Oncol; 2014 Jun; 36(2):125-33. PubMed ID: 24980769
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up.
Costa SD; Lange S; Klinga K; Merkle E; Kaufmann M
Eur J Cancer; 2002 Jul; 38(10):1329-34. PubMed ID: 12091062
[TBL] [Abstract][Full Text] [Related]
13. Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.
Lenhard M; Tereza L; Heublein S; Ditsch N; Himsl I; Mayr D; Friese K; Jeschke U
BMC Cancer; 2012 Nov; 12():553. PubMed ID: 23176303
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.
de Toledo MC; Sarian LO; Sallum LF; Andrade LL; Vassallo J; de Paiva Silva GR; Pinto GA; Soares FA; Fonseca CD; Derchain SF
Acta Histochem; 2014 Apr; 116(3):440-7. PubMed ID: 24238473
[TBL] [Abstract][Full Text] [Related]
15. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
Wei JL; Zhang JX; Fu DY
World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
[TBL] [Abstract][Full Text] [Related]
16. Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
Demir L; Yigit S; Sadullahoglu C; Akyol M; Cokmert S; Kucukzeybek Y; Alacacioglu A; Cakalagaoglu F; Tarhan MO
Asian Pac J Cancer Prev; 2014; 15(22):9739-45. PubMed ID: 25520097
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological characteristics of 'triple-negative' epithelial ovarian cancer.
Liu N; Wang X; Sheng X
J Clin Pathol; 2010 Mar; 63(3):240-3. PubMed ID: 20203223
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
19. Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria.
Ajani MA; Salami A; Awolude OA; Oluwasola AO
Pan Afr Med J; 2017; 27():259. PubMed ID: 29187928
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor status predicts development of brain metastases in ovarian cancers.
Mittica G; Senetta R; Scotto G; Aglietta M; Maggiorotto F; Ghisoni E; Genta S; Boldorini R; Manini C; Morra I; Buosi R; Sapino A; Cassoni P; Valabrega G
Oncotarget; 2017 Jun; 8(25):41143-41153. PubMed ID: 28467804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
